{
    "code": 0,
    "data": [
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please find attached herewith the Intimation regarding appointment of Senior Management Personnel  of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d92981a-9d80-4f61-a9e3-5da10f771be6.pdf",
            "news_date": "2026-02-12 19:05:12"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith the newspaper publication regarding Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=164fee01-902c-4662-a661-8db319039e48.pdf",
            "news_date": "2026-02-12 17:02:03"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith the newspaper publication regarding Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34b4087a-e442-42c0-b93e-2aac3e82311f.pdf",
            "news_date": "2026-02-12 16:40:37"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please find attached the Resignation Letters of Whole Time Directors of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d7a577c-7deb-4b1f-864c-28862c2abce2.pdf",
            "news_date": "2026-02-10 18:20:21"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Please find enclosed herewith the Intimation regarding Fixation of Record Date for an Interim Dividend for the Financial Year 2025-2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4ff4d0a-38d1-442b-b3a8-efd97945f018.pdf",
            "news_date": "2026-02-10 17:00:11"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019",
            "news_body": "Please find attached the outcome of the Nomination and Remuneration Committee Meeting held today i.e. February 10 2026 with regard to the grant of 338000 stock options under Bliss GVS Pharma Limited - Employee Stock Option Plan 2019",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=045e8a36-0afa-4c8e-a6d8-d3097063f845.pdf",
            "news_date": "2026-02-10 16:50:59"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Details Of Kmps For Reporting Of Disclosure Of Material Events To Stock Exchanges",
            "news_body": "Please find attached the details of KMPs for reporting Disclosure of Material Events to Stock Exchanges.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e24bb21-d7e3-41dc-b075-e2a78cdd70f6.pdf",
            "news_date": "2026-02-10 16:39:25"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Tuesday February 10 2026",
            "news_body": "Please find enclosed herewith the Outcome of the Board Meeting held on February 10 2026.",
            "news_id": "8dbcd76c-f9dd-451d-a5cc-0c667a273424",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26cda15c-8e7d-456e-96e9-59883a60df9a.pdf",
            "news_date": "2026-02-10 15:22:39",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Tuesday February 10 2026",
            "news_body": "Please find enclosed herewith the Outcome of the Board Meeting held on February 10 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26cda15c-8e7d-456e-96e9-59883a60df9a.pdf",
            "news_date": "2026-02-10 15:22:39"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday February 10 2026",
            "news_body": "The Board Meeting of Bliss GVS Pharma Limited (the Company) was held today i.e. Tuesday February 10 2026 at the registered office of the Company has considered and approved the following matter(s) amongst others-\r\n1. Approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2025. A copy of unaudited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report of the Auditors of the Company for the quarter and nine months ended December 31 2025 are enclosed herewith as Annexure-1; and \r\n2. Declared the Interim dividend of 50% i.e. 0.50 paisa per equity share on face value of Re.1/- each for the financial year 2025-2026. The Interim Dividend shall be paid within 30 days from the date of its declaration.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e174c2d-398d-4c5b-9435-2265d3e3c5b0.pdf",
            "news_date": "2026-02-10 14:58:31"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for The Meeting Board Of Directors Of The Company Is Scheduled To Be Held On Tuesday February 10 2026.",
            "news_body": "Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve 1. The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2025.\r\n2. The Interim Dividend if any for the financial year 2025-2026.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a3c7557-c140-4884-84e4-c66a9b46fa00.pdf",
            "news_date": "2026-02-03 18:27:34"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Please find enclosed herewith the Scrutinizer Report alongwith the Voting Results.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63b7dba5-fe01-4202-848c-b49835a79592.pdf",
            "news_date": "2026-01-30 18:04:43"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "Please find enclosed herewith the Voting Result alongwith the Scrutinizer Report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48d4e1eb-9c16-4c72-bbe6-500492226f63.pdf",
            "news_date": "2026-01-30 18:02:03"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we would like to inform you that Bliss GVS International PTE Ltd. Singapore a wholly owned subsidiary of Bliss GVS Pharma Limited has incorporated a wholly-owned subsidiary namely Theralife Pharma RDC Private Limited Kinshasa Gombe Democratic Republic of the Congo.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b93bf75f-24fd-437c-bc48-79424c72e52c.pdf",
            "news_date": "2026-01-27 18:44:04"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find enclosed herewith the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=107dd32b-f862-47c7-bd1b-96683a5571c2.pdf",
            "news_date": "2026-01-05 12:04:34"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith an advertisement published in the Newspaper confirming the dispatch of the Postal Ballot Notice.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1acec9eb-50e8-41d2-8b07-a0220e8a276a.pdf",
            "news_date": "2025-12-31 12:32:05"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Please find enclosed herewith the Postal Ballot Notice dated December 30 2025 along with the Explanatory Statement for seeking approval of members of the Company by way of remote e-voting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5e66f8b-49ea-4bd4-b069-1abd1b74de7a.pdf",
            "news_date": "2025-12-30 16:55:41"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Please find enclosed herewith the intimation regarding the Closure of the Trading Window.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33e180f7-27be-4d25-858e-783d30006e5d.pdf",
            "news_date": "2025-12-30 12:54:16"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please find enclosed herewith the Intimation regarding the appointment of Mr S. N Kamath as the Managing Director of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5edb445-165d-4b14-8a1b-ec727ec318f8.pdf",
            "news_date": "2025-12-23 16:36:33"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday December 23 2025",
            "news_body": "We would like to inform you that the Board Meeting of the Company was held today i.e. on Tuesday December 23 2025 at the registered office of the Company through Video Conferencing. In pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Board has considered and approved the matters as enclosed herewith. \r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=818608af-d26f-4788-84ba-e646aca6c6b5.pdf",
            "news_date": "2025-12-23 14:07:06"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. December 09 2025 has approved the allotment of 66380 equity shares of face value Re.1 /- each to the eligible employees who have exercised their options under Bliss GVS Pharma Limited-Employee Stock Option Plan (Bliss GVS -ESOP 2019)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fbb88076-5e07-40df-a1ad-827ceacc4b79.pdf",
            "news_date": "2025-12-09 17:21:19"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Please find enclosed herewith intimation regarding incorporation of step down wholly owned subsidiary of Bliss GVS Pharma Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce5688aa-4403-432a-9f35-0befe039dd29.pdf",
            "news_date": "2025-11-25 20:09:43"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith the copies of newspaper advertisement published pertaining to ongoing bi-monthly communications regarding the Special Window for Re-Lodgement of Transfer Requests of Physical Shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93a36d27-f1d6-44fa-bf3b-320d2e137c2f.pdf",
            "news_date": "2025-11-24 13:04:04"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith the newspaper publication regarding Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a30e2e46-400f-4e80-a5c9-2fda932a7840.pdf",
            "news_date": "2025-11-10 12:02:11"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019",
            "news_body": "Please find attached the outcome of Nomination and Remuneration Committee Meeting held on today i.e. Thursday November 06 2025 with regard to Grant of 553000 stock options under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34aabe8a-1804-463a-bc30-c46d5040e4f4.pdf",
            "news_date": "2025-11-06 21:46:16"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Details Of Kmps For Reporting Of Disclosure Of Material Events To Stock Exchanges",
            "news_body": "Please find attached the details of KMPs for reporting of Disclosure of Material Events to Stock Exchanges.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5597d5d3-d46b-4ca6-ac81-b0833dfa9430.pdf",
            "news_date": "2025-11-06 21:18:40"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please find attached the resignation of Mr. Gagan Harsh Sharma Managing Director of the Company with effect from November 06 2025 along with his resignation letter.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=730cf7fa-a509-4e5e-8abd-701ecd39177f.pdf",
            "news_date": "2025-11-06 21:12:55"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please find attached the Resignation of Mr. Gagan Harsh Sharma Managing Director of the Company with effect from November 06 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c66399f0-4691-4768-9918-1afae1e84729.pdf",
            "news_date": "2025-11-06 21:03:04"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Yearly Ended September 30 2025",
            "news_body": "Please find attached the unaudited standalone and consolidated financial results for the quarter and half yearly ended September 30 2025.",
            "news_id": "3612f58c-cebe-4db1-96ae-d084ac8f5ebb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9fde745-9e3e-4712-869a-bc028b3247ac.pdf",
            "news_date": "2025-11-06 20:54:18",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Yearly Ended September 30 2025",
            "news_body": "Please find attached the unaudited standalone and consolidated financial results for the quarter and half yearly ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9fde745-9e3e-4712-869a-bc028b3247ac.pdf",
            "news_date": "2025-11-06 20:54:18"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday November 06 2025",
            "news_body": "Please find attached herewith the Outcome of Board Meeting held on Thursday November 06 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5af14db1-24bc-4dd8-858b-10203d99e89b.pdf",
            "news_date": "2025-11-06 20:44:05"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. November 05 2025 has approved the allotment of 33670 equity shares of face value Re. 1/- each to the eligible employees who have exercised their options under Bliss GVS Pharma Limited- Employee Stock Option Plan (Bliss GVS-ESOP 2019)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1117b502-3032-4d2f-97dd-c5c2541ccaec.pdf",
            "news_date": "2025-11-05 16:57:56"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6165df2-086a-49cf-b4b0-c4ee48c93ce4.pdf",
            "news_date": "2025-10-29 15:50:48"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. October 10 2025 has approved the allotment of 39450 equity shares of face value Re. 1/- each to the eligible employees who have exercised their options under Bliss GVS Pharma Limited-Employee Stock Option Plan (Bliss GVS-ESOP 2019)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=862da447-9e70-446f-8d6c-03ec30eae523.pdf",
            "news_date": "2025-10-10 18:49:09"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Please find attached the intimation regarding the Show Cause Notice issued by the Joint Commissioner of CGST and Central Excise Mumbai.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c78be25d-e18a-45a0-8220-01a9237a9616.pdf",
            "news_date": "2025-10-06 19:50:43"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find attached herewith the certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d91d0620-7f5b-4112-939a-d69c835952c7.pdf",
            "news_date": "2025-10-06 18:31:00"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Please find enclosed herewith the intimation regarding the Closure of Trading Window.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=549ecd11-1855-4fa0-b062-ad5768ac3b08.pdf",
            "news_date": "2025-09-30 19:01:41"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "We would like to inform you that the Board has considered and approved the appointment of Mr. Narsimha Shibroor Kamath Promoter of the Company as the Chief Executive Officer of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f93345bb-d2bd-44d4-9748-32f6160fc4fa.pdf",
            "news_date": "2025-09-30 18:56:31"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday September 30 2025",
            "news_body": "We would like to inform you that the Board has considered and approved the appointment of Mr. Narsimha Shibroor Kamath Promoter of the Company as Chief Executive Officer of the Company with effect from September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d8a74e0-2d59-4195-9988-aa7658a2ddaa.pdf",
            "news_date": "2025-09-30 18:52:42"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. Monday September 15 2025 has approved the allotment of 39950 equity shares of face value Re 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan (\"Bliss GVS-ESOP 2019\")",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0e54ab8-6679-4eb6-84d4-9ad6d1cad2b4.pdf",
            "news_date": "2025-09-15 17:31:31"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Please find enclosed herewith the Intimation regarding the Review of Credit Rating of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63ee86ae-6fb3-4c1c-accd-a7e55963dfc7.pdf",
            "news_date": "2025-09-03 19:06:44"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. Friday August 29 2025 has approved the allotment of 38000 equity shares of face value Rs. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan (\"Bliss GVS ESOP-2019\")",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c48c922-81f6-413b-98d7-876387505abc.pdf",
            "news_date": "2025-08-29 17:35:49"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith the Newspaper Advertisement regarding intimation of Special Window for re-lodgment of Transfer Request of Physical shares and Special Drive for Updation of KYC and other related Updations to prevent Transfer on Unpaid/Unclaimed Dividends to IEPF.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f46138ca-60a1-4725-b4d2-11354c94ce72.pdf",
            "news_date": "2025-08-08 12:37:32"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Please find attached herewith the disclosure of the Voting Result of the 40th AGM of Bliss GVS Pharma Limited held on Thursday July 31 2025 along with the Scrutinizers Report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8acbea5a-5897-4ef8-ba56-5e3c44ecbd33.pdf",
            "news_date": "2025-08-01 19:37:50"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Proceedings Of 40Th Annual General Meeting Of Bliss GVS Pharma Limited",
            "news_body": "Please find attached herewith the proceedings of 40th Annual General Meeting of Bliss GVS Pharma Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a326d38-92b1-4120-8b6e-abd1a33cac19.pdf",
            "news_date": "2025-07-31 19:23:57"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith copies of the Newspaper Publication regarding the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=450b3b97-3d43-4044-b60a-a9b6575a02ba.pdf",
            "news_date": "2025-07-31 17:02:27"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019",
            "news_body": "Grant of 268000 stock options under Bliss GVS Pharma Limited - Employee Stock Option Plan 2019.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=223648de-eeb3-4a84-90b0-94d6e4d45ad2.pdf",
            "news_date": "2025-07-29 18:37:29"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Tuesday July 29 2025",
            "news_body": "We wish to inform you that the Board of Directors at its meeting held today i.e. Tuesday July 29 2025 has considered and approved the unaudited standalone and consolidated financial results for the quarter ended June 30 2025.",
            "news_id": "8ed32e93-1f66-458b-afaa-fa1212ba6573",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9d22cd4-35e4-434a-8657-51f2cb5e952a.pdf",
            "news_date": "2025-07-29 18:25:07",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Tuesday July 29 2025",
            "news_body": "We wish to inform you that the Board of Directors at its meeting held today i.e. Tuesday July 29 2025 has considered and approved the unaudited standalone and consolidated financial results for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9d22cd4-35e4-434a-8657-51f2cb5e952a.pdf",
            "news_date": "2025-07-29 18:25:07"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday July 29 2025",
            "news_body": "We would like to inform you that the Board Meeting of the Company was held today i.e. on Tuesday July 29 2025 at the registered office of the Company. In pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Board has considered and approved the the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2025. A copy of unaudited standalone and consolidated financial results along with the Limited Review Report of the Auditors.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=797df901-bfb4-4413-9a1e-f636dacb290d.pdf",
            "news_date": "2025-07-29 18:17:16"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "We would like to inform you that the ESOP Allotment Committee at its meeting held on July 28 2025 has approved the allotment of 74000 equity shares of face value Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan (\"Bliss GVS ESOP-2019\")",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e120c4a4-cd5b-4fe9-b0b8-e1fa10079e74.pdf",
            "news_date": "2025-07-28 15:45:57"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2025",
            "news_body": "Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2025. Please find enclosed intimation in this regard",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f1702c8-8579-4b5e-a1fa-2e24c3a635b9.pdf",
            "news_date": "2025-07-22 15:46:46"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith Newspaper Advertisement of Notice of 40th Annual General Meeting e-voting and Book Closure Information.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af1cd8e4-ed14-46ac-a4be-2c92b819820c.pdf",
            "news_date": "2025-07-10 17:14:27"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Please find enclosed herewith the Business Responsibility and Sustainability Report for the FY 2024-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a09f05c5-8c0c-4ab5-9305-8c448e7ded9c.pdf",
            "news_date": "2025-07-09 20:45:10"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of The 40Th Annual General Meeting (40Th AGM) Of Bliss GVS Pharma Limited",
            "news_body": "Please find enclosed herewith the Notice of the 40th AGM of Bliss GVS Pharma Limited (\"the Company\") scheduled to be held on Thursday July 31 2025 at 11:30 A.M. (IST) through VC/OAVM. The said Notice forms part of the Annual Report of the Company for the FY 2024-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eef35d65-3db1-4224-965e-eb76405a6c3f.pdf",
            "news_date": "2025-07-09 20:28:09"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Pursuant to Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) please find enclosed the Notice convening the 40th AGM and the Annual Report of the Company including Business Responsibility and Sustainability Report for the financial year 2024-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=083c7bbb-21cb-4261-a80e-1f2c2edb7557.pdf",
            "news_date": "2025-07-09 20:19:23"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Intimation",
            "descriptor": "Book Closure",
            "caption": "Intimation Of Book Closure In Accordance With Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)",
            "news_body": "Please find enclosed herewith the Intimation for Book Closure for the purpose of the 40th Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28c0850e-6b99-4abd-a26d-71ffaec5eda0.pdf",
            "news_date": "2025-07-08 18:02:17"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of Record Date In Accordance With Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)",
            "news_body": "Please find enclosed herewith the Intimation regarding Fixation of Record Date for the payment of Final Dividend for the financial year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57c62346-9f9c-479a-bac0-26c202c65c7d.pdf",
            "news_date": "2025-07-08 17:56:43"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith the Newspaper Publication regarding 40th Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28d16ee2-0d50-4db9-957f-7f71f2a47915.pdf",
            "news_date": "2025-07-08 11:54:50"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Communication To Shareholders - Intimation Of Tax Deduction On Dividend",
            "news_body": "Please find enclosed herewith the communication sent to shareholders regarding Intimation of Tax Deduction on Dividend.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4271f98e-bd1a-450a-8b47-e45d7b27bda0.pdf",
            "news_date": "2025-07-08 11:48:56"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find enclosed the certificate received under Regulation 74(5) of SEBI (DP) Regulation 2018 for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=edeb0e54-1236-4bc9-9f8e-edc67e11937f.pdf",
            "news_date": "2025-07-04 19:14:58"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Please find attached the intimation regarding the Show Cause Notice issued by the Joint Commissioner of CGST and Central Excise Mumbai.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d05cef7d-5664-4d7a-a6d4-7ad13e5dbe7e.pdf",
            "news_date": "2025-07-02 17:10:55"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Gagan Harsh Sharma & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=A0981351_6618_4A8D_B79A_5564214A769A_100010.pdf",
            "news_date": "2025-07-01 10:00:24"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "We would like to inform you that the ESOP Allotment Committee at its meeting held on June 30 2025 has approved the allotment of 52000 equity shares of face value Re. 1/- each to the eligible employees who have exercised their stock options under the Bliss GVS Pharma Limited- Employee Stock Option Plan (\"Bliss GVS ESOP-2019\")",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=132ff523-96ea-449d-ada6-9f46da1fc251.pdf",
            "news_date": "2025-06-30 18:19:21"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith the Publication of Notice to Shareholders for Transfer of Unclaimed Final Dividend 2017-2018 and its corresponding shares to IEPF Authority.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fe5c8e9-32f1-4392-b242-1a9b8ac45a8c.pdf",
            "news_date": "2025-06-30 15:48:50"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Notice To Shareholders W.R.T. Transfer Of Unclaimed Final\r\nDividend 2017-2018 And Its Corresponding Shares To Investor\r\nEducation And Protection Fund (IEPF) Authority",
            "news_body": "Please find enclosed herewith the Notice sent to the Shareholders of the Company w.r.t. Transfer of Unclaimed Final Dividend 2017-2018 and its corresponding shares to the IEPF Authority.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6a0a463-69af-4de6-984a-40f9e6710daf.pdf",
            "news_date": "2025-06-30 12:01:09"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Please find enclosed the Intimation regarding the Closure of the Trading Window w.e.f. July 01 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9e34086-f950-4649-8103-8e8cc876b668.pdf",
            "news_date": "2025-06-30 11:42:43"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Gagan Harsh Sharma & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=F042B7C8_F900_4C67_B692_EC73B543C338_083658.pdf",
            "news_date": "2025-06-26 08:37:01"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "In connection with the Postal Ballot Notice dated May 12 2025 please find enclosed herewith the outcome of the Postal ballot along with the Scrutinizers Report and the Voting Results under Regulation 44 of the Listing Regulations.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2bbb9eac-beca-4b66-8c1e-15d0c8a8c79f.pdf",
            "news_date": "2025-06-12 16:08:30"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "In connection with the Postal Ballot Notice dated May 12 2025 please find enclosed herewith the outcome of the Postal Ballot along with the Scrutinizers Report and Voting Results under Regulation 44 of the Listing Regulations.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39d3deab-116f-49d7-87a4-9e0bbeae197e.pdf",
            "news_date": "2025-06-12 16:05:07"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Gagan Harsh Sharma & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=A401883B_DEEF_4303_90D9_74E8C58BAA75_094909.pdf",
            "news_date": "2025-06-12 09:49:13"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "We like to inform you that the ESOP Allotment Committee of the Company at its meeting held on June 06 2025 has approved the allotment of 75250 equity shares of the face value of Rs. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited- Employee Stock Option Plan (\"Bliss GVS ESOP-2019\")",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c10769f-1f6a-4fa0-8244-eb8d40deefe1.pdf",
            "news_date": "2025-06-06 12:55:41"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Please find enclosed herewith the Annual Secretarial Compliance Report for the year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3bffca11-6cbe-42a3-a2b4-b3e8aa79e9cc.pdf",
            "news_date": "2025-05-29 16:36:24"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Gagan Harsh Sharma & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37731459_15F4_4341_B894_FEA125409CC1_123534.pdf",
            "news_date": "2025-05-26 12:35:38"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On Legal Proceeding",
            "news_body": "Enclosed herewith please find attached an update on the legal proceeding - Commercial Suit for Infringement of Intellectual Property Rights.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c62da8a-dd23-44ff-803a-8f7c84b8a211.pdf",
            "news_date": "2025-05-23 16:25:22"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Gagan Harsh Sharma & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89C1EB38_8059_499E_8440_88DBFD1D3681_111732.pdf",
            "news_date": "2025-05-23 11:17:34"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith the copies of the Newspaper Publication regarding the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83d8b037-1ac6-4f0d-a78f-7789962b153a.pdf",
            "news_date": "2025-05-14 15:14:09"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith an advertisement published in the newspaper confirming the dispatch of the Postal Ballot Notice.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af15ec29-bf5d-490b-bbad-26f1c5f65488.pdf",
            "news_date": "2025-05-13 13:34:36"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019",
            "news_body": "Grant of 862000 Stock Option under Bliss GVS Pharma Limited- Employee Stock Option Plan 2019",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb2ec614-c44a-4bd7-8619-cab2ea05072b.pdf",
            "news_date": "2025-05-12 22:17:40"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Internal Auditor and Secretarial Auditor.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=214b5341-76b2-470c-a08a-0280a99c7eef.pdf",
            "news_date": "2025-05-12 22:04:13"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated Filing (Financial) for the quarter and year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38b5ee7f-ef18-4e2c-8175-9bcb2d98b3d8.pdf",
            "news_date": "2025-05-12 21:53:26"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Notice of Postal Ballot dated May 12 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e841317c-9f7e-4d25-aaea-953270c8b4e1.pdf",
            "news_date": "2025-05-12 21:32:39"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Book Closure In Accordance With Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "According to Section 91 of the Companies Act 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (\"Listing Regulations\") we hereby inform you that the Register of Members and Share Transfer Books of the Company will remain closed from Friday July 25 2025 to Thursday July 31 2025 (both days inclusive) for 40th AGM.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23414a8f-fab5-40c3-afc2-f1edfab3f549.pdf",
            "news_date": "2025-05-12 21:24:50"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "Dividend/AGM",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Declaration of Final Dividend for the Financial Year Ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=660c763c-d4b6-4ca8-865c-bfeb3fac68ca.pdf",
            "news_date": "2025-05-12 21:09:34"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On May 12 2025.",
            "news_body": "We would like to inform you that the Board Meeting of the Company was held today i.e. Monday May 12 2025 at the registered office of the Company. In pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Board has considered and approved the matters amongst others as attached.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc09ab6c-5948-4c88-8d03-e43b709bac28.pdf",
            "news_date": "2025-05-12 21:00:43"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Issue of Securities",
            "caption": "Announcement under Regulation 30 (LODR)-Issue of Securities",
            "news_body": "The Board of Directors in its meeting held today i.e. May 12 2025 has approved the issuance and allotment of Sweat Equity shares to the members of the Promoter and Promoter Group of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33ae1241-af6e-4949-8f3e-ef7c9913d636.pdf",
            "news_date": "2025-05-12 19:10:08"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Update on board meeting",
            "news_body": "Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve Update on board meeting- To consider and approve the proposal for issuance of Sweat Equity Shares. Enclosed herewith please find attached intimation in this regard.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1929422f-20d9-4bf1-855d-b5c837e3e642.pdf",
            "news_date": "2025-05-07 18:30:14"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Year Ended March 31 2025 And Recommendation Of Final Dividend If Any For The Year Ended March 31 2025.",
            "news_body": "Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve a) The Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2025 along with the Statement of Assets and Liabilities Cash Flow Statement and take note of the Audit Report with modified opinion if any thereon.\r\nb) The Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31 2025 and\r\nc) Recommend the Final Dividend if any for the financial year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e7b4da4-24f1-41fa-93f5-332b834841e4.pdf",
            "news_date": "2025-05-05 19:51:14"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI (LODR) Regulation 2015- Pendency Of Litigation(S)/Dispute(S)\r\n",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Bliss GVS Pharma Limited (hereinafter referred to as \"the Company\") had invoked arbitration proceedings against PAN Pharmaceuticals Limited (Nairobi Kenya) for recovery of its outstanding dues by way of filing a petition seeking appointment of an arbitrator before the Supreme Court of India. Enclosed herewith please find the intimation in this regard.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6fc0fc52-3f6c-4a7e-9196-aa81dd3a04f0.pdf",
            "news_date": "2025-05-03 10:25:38"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Compliance",
            "descriptor": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ",
            "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
            "news_body": "  <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Bliss GVS Pharma Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24230MH1984PLC034771</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>47.59</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>BBB+STABLE</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CRISIL LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table>  <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Aditi Bhatt <br/>  Designation: Company Secretary <br/> EmailId: cs@blissgvs.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Deepak Sawant <br/> Designation: Chief Financial Officer <br/> EmailId: deepak.sawant@blissgvs.com</div> </div> <div> <br/> Date: 30/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e05d9a91-acf1-43e2-b592-cb5e99a3bb7b.pdf",
            "news_date": "2025-04-30 12:07:23"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Change In Contact Details Of MUFG Intime India Private Limited Registrar And Share Transfer Agent Of The Company.",
            "news_body": "Please find attached the Intimation regarding change in contact details of MUFG Intime Private Limited (Formerly known as Link Intime India Private Limited) Registrar and Share Transfer Agent of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a863f41-11c1-4eac-99c7-4859f4a33ea4.pdf",
            "news_date": "2025-04-22 18:24:08"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI (LODR) Regulation 2015.",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we would like to inform you that the Rising Pharma Holdings Inc. USA a marketing and distribution partner of bliss GVS Pharma Limited (\"the Company\") has been granted final approval from the U.S. Food & Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) for its product \"Mesalamine Suppositories 1000 mg\". The ANDA was submitted through our partner in the USA.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=141292bf-5b50-4611-9ad6-6213a1d0f898.pdf",
            "news_date": "2025-04-15 15:31:02"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Pendency Of Litigation(S)/Dispute(S)",
            "news_body": "This is a continuation of our communication dated March 26 2021 regarding the commercial suit for infringement of Intellectual Property Rights. We previously informed you that Bliss GVS Pharma Limited (\"the Company\") had filed a suit in the High Court of Justice Ghana in its Commercial Division against the infringing party (\"the Defendant\") concerning the illegal manufacture of the Companys registered trademark by the Defendant. Please find enclosed herewith the intimation about the decision on commercial suit for infringement of intellectual property rights.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a106c56-db19-4208-9eaa-151c0cd9cdcb.pdf",
            "news_date": "2025-04-12 18:29:38"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find attached herewith a certificate received from MUFG Intime India Private Limited Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities Exchange Board of India (Depositories & Participants) Regulations 2018 for the quarter ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=517b8ac2-4791-4f2a-ae75-e5610b49cb33.pdf",
            "news_date": "2025-04-07 18:27:31"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Enclosed herewith please find attached the intimation regarding the resignation of Mr. Vilas Patil General Manager - Human Resource and a Senior Management Personnel of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af09a5bb-d214-48a8-a7d0-1efaadd0b6d0.pdf",
            "news_date": "2025-03-27 19:34:25"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Please find enclosed herewith the intimation regarding closure of Trading Window.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4df4075-11c4-4adb-b908-9b39e52452cf.pdf",
            "news_date": "2025-03-26 16:39:30"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vibha Gagan Sharma & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7043FA9E_E7E1_46AE_BCDC_E0DEDD19CF6E_194050.pdf",
            "news_date": "2025-03-24 19:40:54"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vibha Gagan Sharma & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5192D980_5DF6_41CA_8A95_E81F8C1B4225_193845.pdf",
            "news_date": "2025-03-24 19:38:49"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vibha Gagan Sharma & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46C3FB81_326B_4F04_B9A9_2D0242547E80_180239.pdf",
            "news_date": "2025-03-24 18:02:42"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Narsimha Shibroor Kamath & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28C40A79_514F_4465_A853_FEFDCA2230E7_170149.pdf",
            "news_date": "2025-02-21 17:01:54"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Narsimha Shiboor Kamath & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ABECEB3_B662_4D51_BCE5_A89EB4391917_101357.pdf",
            "news_date": "2025-02-21 10:14:01"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Please find attached Intergrated Filing (Financial) for the quarter and nine months ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cacce47-1896-4822-bf4d-6b81e43dbce9.pdf",
            "news_date": "2025-01-30 18:51:41"
        },
        {
            "co_code": 79,
            "bse_code": 506197,
            "isin": "INE416D01022",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith the copies of the Newspaper publication regarding the Unaudited Standalone and Consolidated Financial Results of the Company of the Company for the quarter and nine months ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3a8903c-5697-4437-a89e-29a4e7911e30.pdf",
            "news_date": "2025-01-30 12:46:56"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Please find attached the outcome of Board Meeting held on Tuesday January 28 2025.",
            "news_id": "be557f40-b9b9-4b40-a808-398a4395961f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d8e8259-1b09-4cad-9377-3237fcfc95df.pdf",
            "news_date": "2025-01-28 19:32:34",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2024",
            "news_body": "Please find attached herewith the Outome of Board Meeting held on today i.e. July 24, 2024 for approval of Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2024.",
            "news_id": "0d306e2d-5854-4728-a22a-107c2d18228f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a796ae32-e72c-4a45-affa-ba13fd874545.pdf",
            "news_date": "2024-07-24 14:17:03",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31, 2024",
            "news_body": "Please find attached herewith Outcome of the Board Meeting held on May 02, 2024.",
            "news_id": "3367d786-051f-4aff-90b3-d97f643d5436",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7ec929e-baca-4fa9-887e-24a463f7d69b.pdf",
            "news_date": "2024-05-02 21:56:47",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Enclosed herewith the outcome of board meeting held on January 23, 2024",
            "news_id": "8aaa8bf0-d76c-4aec-87e6-2d549dec80ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e92191f-a411-4e93-a37b-48be6876ac0d.pdf",
            "news_date": "2024-01-23 23:36:05",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "We would like to inform you that the Board Meeting of the Company was held today i.e. Wednesday, November 01, 2023, at the registered office of the Company. In pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI Listing Regulations. Enclosed herewith Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2023 along with Limited Review Report.",
            "news_id": "9624be38-88ee-4ede-beee-91880931f113",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b48acac1-1434-459e-9f49-dd5f6cb99b74.pdf",
            "news_date": "2023-11-01 20:35:55",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31, 2023",
            "news_body": "We would like to inform you that, the Board Meeting of the Company was held today i.e. Thursday, May 11, 2023 at the registered office of the Company. In pursuant to                 Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board has considered and approved the matters amongst others as attached.",
            "news_id": "d6241d13-0e61-41ba-bd57-2c11d73e80f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e10fa2cc-0606-422d-927e-a8adc7d02235.pdf",
            "news_date": "2023-05-11 22:48:54",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "We would like to inform you that, Board Meeting of the Company was held today i.e. Tuesday, January 24, 2023 at the registered office of the Company. In pursuant to  Regulation 30 and 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Board has considered and approved the following matter amongst others:<BR> <BR> i. The Unaudited Standalone and Consolidated Financial Results of the company for the quarter and nine months ended December 31, 2022. A copy of unaudited financial results along with the Limited Review Report of the Auditors of the Company are enclosed herewith as 'Annexure - I'.<BR> <BR> The meeting of the Board of Directors commenced at 05:30 p.m. and concluded at 08:55 p.m.<BR>",
            "news_id": "3162a322-e7fa-4612-98e6-bd1ce27b9100",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1b06609-8829-4431-9698-a069fa4bc4ed.pdf",
            "news_date": "2023-01-24 21:08:51",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Clarification W.R.T Submission Of Outcome Of The Board Meeting Held On Monday, November 07, 2022",
            "news_body": "Please find the attachment.",
            "news_id": "ad5096b5-a171-4d30-9ce5-e801c3f86b6f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e0b810d-a3eb-4f96-a336-55045bf4855a.pdf",
            "news_date": "2022-11-23 18:18:24",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, please find enclosed herewith  a disclosure of Related Party Transactions in the specified format for the half year ended  September 30, 2022.Kindly take the same on your record.",
            "news_id": "58f1bbe1-5bff-45d2-b095-b306be024ec2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23a4d578-d5bc-44c4-8c03-d82b89d01f9e.pdf",
            "news_date": "2022-11-21 21:44:54",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2022",
            "news_body": "We would like to inform you that, Board Meeting of the Company was held today i.e. Monday, November 07, 2022 at the registered office of the Company. In pursuant to Regulation 30 and 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Board has considered and approved the following matter amongst others:<BR> <BR> 1. The Unaudited Standalone and Consolidated Financial Results of the company for the quarter and half year ended September 30, 2022. A copy of unaudited financial results along with the Limited Review Report of the Auditors of the Company are enclosed herewith as 'Annexure - I'.<BR> <BR> The meeting of the Board of Directors commenced at 05:30 p.m. and concluded at 07:45 p.m.<BR> <BR>",
            "news_id": "affec892-d069-4bf5-8316-619f6e943130",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ec4f38f-a5af-4fad-8533-b9bf0a328c48.pdf",
            "news_date": "2022-11-07 20:05:17",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, August 03, 2022",
            "news_body": "We would like to inform you that, Board Meeting of the Company was held today i.e. Wednesday, August 03, 2022 at the registered office of the Company. In pursuant to Regulation 30 and 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Board has considered and approved the following matter amongst others:<BR> 1.The Unaudited Standalone and Consolidated Financial Results of the company for the quarter ended June 30, 2022. A copy of unaudited financial results along with the Limited Review Report of the Auditors of the Company are enclosed herewith as 'Annexure - I'.",
            "news_id": "20db96a6-d606-49e7-9f8b-0e5ea20016c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31882a7e-ef40-4737-b588-cf65cfc9e739.pdf",
            "news_date": "2022-08-03 20:46:54",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Saturday, April 30, 2022",
            "news_body": "1.The Audited standalone and consolidated financial results of the Company for the quarter and year ended March 31, 2022 <BR> 2. Recommended Final dividend of 50% i.e. 0.50 paisa per equity share having face value of  Rs.1/- each for the financial year ended March 31, 2022<BR> 3. Re-appointment of M/s. Kalyaniwalla Mistry & LLP, Chartered Accountants (Firm Registration No. 104607W/W100166), Peer Reviewed Firm as the Statutory Auditors <BR> 4. Re-appointment of M/s. BDO India LLP, Chartered Accountant having LLP registration no. AAB-7880 as Internal Auditor of the Company for the financial year 2022-23<BR> 5. Re-appointment of M/s. AVS & Associates, Practicing Company Secretaries, Peer Reviewed Firm as Secretarial Auditor of the Company for the financial year 2022-23<BR> 6. 37th AGM of the Company for the Financial Year 2021-2022 has been scheduled to be held on Tuesday, June 28, 2022 at 11:00 a.m. through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') facility",
            "news_id": "09401cbc-bb61-4129-a57a-c7accdca3888",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2433b646-35aa-4163-accc-6bf38e4c9458.pdf",
            "news_date": "2022-04-30 20:46:31",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2021",
            "news_body": "We would like to inform you that, Board Meeting of the Company was held today                                    i.e. Saturday, January 29, 2022 at the registered office of the Company. In pursuant to                    Regulation 30 and 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Board has considered and approved the following matter amongst others:<BR> 1. The Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2021. A copy of unaudited financial results along with the Limited Review Report of the Auditors of the Company are enclosed herewith as 'Annexure - I'.",
            "news_id": "a9025b92-711e-46c2-a92c-81843e9ffdfc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fe04feb-8175-4003-8cd4-32ec0b73e3bb.pdf",
            "news_date": "2022-01-29 21:13:44",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for  Unaudited Standalone And Consolidated Financial Result For The Quarter And Half Yearly Ended September 30, 2021",
            "news_body": "We would like to inform you that, Board Meeting of the Company was held today  i.e. Saturday, October 30, 2021 at the registered office of the Company. In pursuant to Regulation 30 and 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Board has considered and approved the matters as per attachment.",
            "news_id": "c2a6e2a5-4c5b-45d7-8013-81be0ef8d11e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a5aa26e-f372-42dc-a796-80a5a1e2ee78.pdf",
            "news_date": "2021-10-30 17:51:51",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Result For The Quarter Ended June 30, 2021",
            "news_body": "We would like to inform you that, Board Meeting of the Company was held today i.e. Saturday, July 31, 2021 at the registered office of the Company. In pursuant to Regulation 30 and 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Board has considered and approved the matters as per attachment.",
            "news_id": "fb241702-ab6a-4e11-8c77-de9c7ee242fd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cae3efae-ee87-49ae-bbd9-26525c741402.pdf",
            "news_date": "2021-07-31 17:44:41",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BLISSGVS",
            "disp": "Bliss GVS Pharma",
            "bse_code": 506197,
            "isin": "INE416D01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31, 2021",
            "news_body": "1. Audited standalone and consolidated financial results of the Company for the quarter and year ended March 31, 2021 along with the audit report with declaration of unmodified opinion <BR> <BR> 2. Recommended Final dividend of 50% i.e. 0.50 paisa per equity share on face value of Rs. 1/- each for the financial year ended March 31, 2021<BR> <BR> 3.Re-appointment of M/s. BDO India LLP, Chartered Accountant having LLP registration no. AAB-7880 as Internal Auditor<BR> <BR> 4. Issue & Allotment of 2,10,500 Equity Shares of face value of Rs. 1 each of the Company under 'Bliss GVS Pharma Limited-Employee Stock Option Plan 2019' <BR> <BR> 5.Re-appointment of Mr. Santosh Laxman Parab (DIN:01622988), as an Non-Executive Independent Director of the Company<BR> <BR> 6. Resignation of Mr. S N Kamath from the position of Managing Director <BR> <BR> 7. Appointment of Mr. Gagan Harsh Sharma (DIN:07939421) as Managing Director of the Company<BR> <BR> 8. Reconstitution  of Committees",
            "news_id": "7fd850ad-07f9-405e-8514-9682d7ddf63d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a785be82-b2bc-4c19-861d-5caa956dd20a.pdf",
            "news_date": "2021-05-11 19:41:15",
            "seo": "bliss-gvs-pharma-ltd",
            "ltp": 214.22,
            "ch": 6.150000000000006,
            "pch": 2.9557360503676673,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 19265,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}